Inhaled corticosteroids (ICS) are the FDA-indicated treatment of choice in preventing asthma exacerbations in patients with persistent asthma.

Recently updated guidelines also recommend ICS to be used for acute asthma symptoms in conjunction with beta-2 agonists in adolescents and adults.